Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094743
Filing Date
2024-08-09
Accepted
2024-08-09 16:05:31
Documents
66
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cytk-20240630.htm   iXBRL 10-Q 2508850
2 EX-10.1 cytk-ex10_1.htm EX-10.1 36220
3 EX-10.3 cytk-ex10_3.htm EX-10.3 187241
4 EX-10.4 cytk-ex10_4.htm EX-10.4 87231
5 EX-10.5 cytk-ex10_5.htm EX-10.5 494639
6 EX-10.6 cytk-ex10_6.htm EX-10.6 508228
7 EX-10.7 cytk-ex10_7.htm EX-10.7 157358
8 EX-31.1 cytk-ex31_1.htm EX-31.1 15258
9 EX-31.2 cytk-ex31_2.htm EX-31.2 15343
10 EX-32.1 cytk-ex32_1.htm EX-32.1 8667
11 GRAPHIC img196648343_0.jpg GRAPHIC 2356
  Complete submission text file 0000950170-24-094743.txt   11010740

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cytk-20240630.xsd EX-101.SCH 1495246
68 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20240630_htm.xml XML 1355026
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50633 | Film No.: 241192561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)